References
- Asquith M, Elewaut D, Lin P, Rosenbaum JT. (2014). The role of the gut and microbes in the pathogenesis of spondyloarthritis. Best Pract Res Clin Rheumatol, 28, 687–702.
- Aydin SZ, Atagunduz P, Inanc N, et al. (2007). Mannose binding lectin levels in spondyloarthropathies. J Rheumatol, 34, 2075–2077.
- Boldt AB, Culpi L, Tsuneto LT, et al. (2006). Diversity of the MBL2 gene in various Brazilian populations and the case of selection at the mannose-binding lectin locus. Hum Immunol, 67, 722–734.
- Ciccia F, Rizzo A, Triolo G. (2016). Subclinical gut inflammation in ankylosing spondylitis. Curr Opin Rheumatol, 28, 89–96.
- Colombo E, Latiano A, Palmieri O, et al. (2009). Enteropathic spondyloarthropathy: A common genetic background with inflammatory bowel disease? World J Gastroenterol, 15, 2456–2462.
- Heitzeneder S, Seidel M, Förster-Waldl E, Heitger A. (2012). Mannan-binding lectin deficiency: Good news, bad news, doesn’t matter? Clin Immunol, 143, 22–38.
- Im CH, Kim J, Lee YJ, et al. (2012). Mannose-binding lectin 2 gene haplotype analysis in Korean patients with ankylosing spondylitis. Rheumatol Int, 32, 2251–2255.
- Ip WK, Takahashi K, Moore KJ, et al. (2008). Mannose-binding lectin enhances toll-like receptors 2 and 6 signaling from the phagosome. J Exp Med, 205, 169–181.
- Kovacs M, Papp M, Lakatos PL, et al. (2013). Low mannose-binding lectin (MBL) is associated with paediatric inflammatory bowel diseases and ileal involvement in patients with Crohn disease. J Crohns Colitis, 7, 134–141.
- Laval SH, Timms A, Edwards S, et al. (2001). Whole-genome screening in ankylosing spondylitis: Evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet, 68, 918–926.
- Mathew AJ, Ravindran V. (2014). Infections and arthritis. Best Pract Res Clin Rheumatol, 28, 935–959.
- Müller S, Schaffer T, Flogerzi B, et al. (2010). Mannan-binding lectin deficiency results in unusual antibody production and excessive experimental colitis in response to mannose-expressing mild gut pathogens. Gut, 59, 1493–1500.
- Nisihara R, Skare T, Capeletto CM, et al. (2016). Mannose binding lectin deficiency and susceptibility to infections in patients with rheumatoid arthritis. Rheumatology (Oxford), 55, 951–952.
- Palm NW, de Zoete MR, Flavell RA. (2015). Immune-microbiota interactions in health and disease. Clin Immunol, 159, 122–127.
- Panda AK, Parida JR, Tripathy R, et al. (2012). Mannose binding lectin: A biomarker of systemic lupus erythematosus disease activity. Arthritis Res Ther, 14, R218. doi:10.1186/ar4057
- Petersen S, Thiel S, Jensen L, et al. (2001). An assay for the mannan-binding lectin pathway of complement activation. J Immunol Methods, 257, 107–116.
- Reveille JD, Brown M. (2010). Epidemiology of ankylosing spondylitis: IGAS 2009. J Rheumatol, 37, 2624–2625.
- Sieper J, Rudwaleit M, Baraliakos X, et al. (2009). The Assessment of SpondyloArthritis international Society (ASAS) handbook: A guide to assess spondyloarthritis. Ann Rheum Dis, 68(Suppl 2), ii1–44.
- Sørensen CM1, Hansen TK, Steffensen R, et al. (2006). Hormonal regulation of mannan-binding lectin synthesis in hepatocytes. Clin Exp Immunol, 145, 173–182.
- Stoll ML. (2015). Gut microbes, immunity, and spondyloarthritis. Clin Immunol, 159, 134–142.
- Takahashi R, Tsutsumi A, Ohtani K, et al. (2005). Association of mannose binding lectin (MBL) gene polymorphism and serum MBL concentration with characteristics and progression of systemic lupus erythematosus. Ann Rheum Dis, 64, 311–314.
- Tito RY, Cypers H, Joossens M, et al. (2016) Jul 7. Dialister as microbial marker of disease activity in spondyloarthritis. Arthritis Rheumatol. doi: 10.1002/art.39802 [Epub ahead of print].
- Zuo DM, Zhang LY, Lu X, et al. (2009). Protective role of mouse MBL-C on intestinal mucosa during Shigella flexneri invasion. Int Immunol, 21, 1125–1134.